AAPS and the AAPS Board of Directors congratulate the newly elected leadership.
AAPS is pleased to announce that members have elected the following individuals to the AAPS Board of Directors. Their terms of office begin on October 24, 2024, after PharmSci 360.
The Board of Directors thanks all the members who voted in this year’s election. Your support of AAPS helps make the organization vibrant and effective in the pursuit of AAPS' mission: To advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.
Subramanyam, Templeton, and Coker will join the following members on the 2025 Board of Directors: 2025 President Russell S. Weiner, Ph.D., FAAPS; Immediate Past President Gopi Shankar, Ph.D., M.B.A., FAAPS; and Members-at-Large Nikoletta Fotaki, Ph.D., FAAPS; Amanda Hays, Ph.D.; Aliasger Salem, Ph.D., FAAPS; and Peter W. Swaan, Ph.D., FAAPS.